Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)
Clinical trial NCT01397734 · TERMINATED
Trial details
- NCT number
- NCT01397734
- Sponsor
- Beth Israel Deaconess Medical Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2018-08-06
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.